RNLX Renalytix PLC

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Renalytix AI (RNLX - Research Report), with a price target of $8.00. The company's shares opened today at $2.13.Chen covers the Healthcare sector, focusing on stocks such as Veru, Applied DNA Sciences, and Aslan Pharmaceuticals. According to TipRanks, Chen has an average return of -32.4% and a 21.81% success rate on recommended stocks. Renalytix AI has an analyst consensus of Moderate Buy, with a price target consensus of $6.00.See the top stocks recommended by analysts >>The company has a one-year high of $17.83 and a one-year low of $1.05.
https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-renalytix-ai-rnlx?utm_source=advfn.com&utm_medium=referral